AI assistant
Sending…
TherapeuticsMD, Inc. — Director's Dealing 2022
Aug 22, 2022
35134_dirs_2022-08-22_756eea14-1084-4717-ac12-4ad6fe5a0c28.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2022-08-18
Reporting Person: Ling Karen (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-18 | Common Stock | M | 1984 | — | Acquired | 4591 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-08-18 | Restricted Stock Units | $0.00 | M | 1984 | Disposed | Common Stock (1984) | Direct |
Footnotes
F1: On August 18, 2022, the reporting person received 1,984 shares of common stock of the issuer in settlement of restricted stock units (RSUs), which vested on July 1, 2022.
F2: Each RSU represents a contingent right to receive one share of issuer common stock upon settlement.
F3: The RSUs vested on July 1, 2022.
More from TherapeuticsMD, Inc.
Interim / Quarterly Report
2026
May 12
Regulatory Filings
2026
May 12
Major Shareholding Notification
2026
Apr 7
Annual Report
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 30
Annual Report
2026
Mar 30
Regulatory Filings
2026
Jan 20
Director's Dealing
2025
Dec 29
Regulatory Filings
2025
Dec 16